Literature DB >> 8044613

Multicentre audit of death from acute pancreatitis.

D V Mann1, M J Hershman, R Hittinger, G Glazer.   

Abstract

A prospective audit of acute pancreatitis involving nine hospitals in the North-West Thames Region recruited 631 patients over 54 months. There were 57 deaths (9 per cent); a diagnosis had been reached in 50 patients (88 per cent) before death and in seven (12 per cent) at autopsy. Eighteen patients (32 per cent) died within the first week, usually as a result of multisystem organ failure (15 patients). Thirty-nine patients (68 per cent) died after the first week from complications related to infection (26 patients) co-morbid conditions (nine) or non-infective complications (four). Twenty-one patients (42 per cent) had been inadequately evaluated by Ranson's criteria, and only 22 (44 per cent) of 50 with a premortem diagnosis of pancreatitis had undergone computed tomography (CT). Fifteen of 26 patients who died from infection-related complications had CT and only nine underwent necrosectomy or surgical drainage. These data suggest that improved diagnosis, investigation and management of patients with acute pancreatitis is possible, and may result in improved clinical outcome.

Entities:  

Mesh:

Year:  1994        PMID: 8044613     DOI: 10.1002/bjs.1800810632

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  51 in total

1.  A useful mnemonic for severity stratification in acute pancreatitis.

Authors:  E M Moore
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

2.  Can ultrasound predict the severity of acute pancreatitis early by observing acute fluid collection?

Authors:  Y Luo; C X Yuan; Y L Peng; P L Wei; Z D Zhang; J M Jiang; L Dai; Y K Hu
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Vasoactive intestinal peptide promotes gut barrier function against severe acute pancreatitis.

Authors:  Lu Zhongkai; Ye Jianxin; Chen Weichang
Journal:  Mol Biol Rep       Date:  2011-07-03       Impact factor: 2.316

5.  Role of cytokines and their inhibitors in acute pancreatitis.

Authors:  A Kingsnorth
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

6.  Role of bedside pancreatic scores and C-reactive protein in predicting pancreatic fluid collections and necrosis.

Authors:  Doraiswami Babu Vinish; Vishnu Abishek; K Sujatha; S Arulprakash; Rajkumar Solomon; P Ganesh
Journal:  Indian J Gastroenterol       Date:  2017-02-09

7.  Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage.

Authors:  Ping Xue; Li-Hui Deng; Qing Xia; Zhao-Da Zhang; Wei-Ming Hu; Xiao-Nan Yang; Bing Song; Zong-Wen Huang
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

8.  Gallstone Pancreatitis.

Authors:  Tony C. K. Tham; David R. Lichtenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2002-10

Review 9.  Antibiotic prophylaxis of pancreatic infection in patients with necrotizing pancreatitis: rationale, evidence, and recommendations.

Authors:  Issac Moyshenyat; Ephraim Mandell; Scott Tenner
Journal:  Curr Gastroenterol Rep       Date:  2006-04

10.  JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis.

Authors:  Miho Sekimoto; Tadahiro Takada; Yoshifumi Kawarada; Koichi Hirata; Toshihiko Mayumi; Masahiro Yoshida; Masahiko Hirota; Yasutoshi Kimura; Kazunori Takeda; Shuji Isaji; Masaru Koizumi; Makoto Otsuki; Seiki Matsuno
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.